Bk Virus Infection
📧 Sign up to get email alerts when something new happens for Bk Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Prediction of BK Virus Reactivation in Kidney Transplant Recipient [NA]
A completed clinical trial evaluating predictors of BK virus reactivation in kidney transplant recipients; the snippet does not provide resu…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients [Phase 2, Phase 3]
This clinical trial update indicates that Phase 2 and Phase 3 studies of AntiBKV for BK virus infection in kidney transplant recipients have…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation. [Phase 4]
Phase 4 trial evaluating whether intravenous immunoglobulins can prevent BK virus infection in kidney transplant recipients, stratified by B…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating donor-derived T lymphocytes for infections caused by adenovirus, cytomegalovirus, Epstein-Barr virus,…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: BK With VST for Kidney Transplant Patients [Phase 1]
Phase 1 trial evaluating virus-specific T cells (VST) for BK virus infection in kidney transplant recipients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation [Phase 2]
Phase 2 study to assess safety and tolerability of brincidofovir in kidney transplant recipients with BK virus infection (viremia); the tria…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia [Phase 2]
Phase 2 study of Posoleucel (formerly ALVR105; Viralym-M) in kidney transplant patients with BK viremia has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reports termination of a Phase 2/Phase 3 study of posoleucel (ALVR105, Viralym-M) for multi-virus prevention in patien…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) [Phase 3]
Phase 3 study evaluating Viralym-M (ALVR105) for virus-associated hemorrhagic cystitis, including BK virus infection, was terminated with re…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reporting completed results for Posoleucel (ALVR105) studied to prevent multiple viral infections after allogeneic hem…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients [Phase 2]
Phase 2 trial update for MAU868 assessing safety, pharmacokinetics, and efficacy in BK virus infection among kidney transplant recipients ha…
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: CMX001 in Post-transplant Patients With BK Virus Viruria [Phase 1, Phase 2]
Clinical trial update for CMX001 in post-transplant patients with BK virus viruria (Phase 1/Phase 2) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Ciprofloxacin for Prevention of BK Infection [Phase 4]
Phase 4 clinical trial evaluating ciprofloxacin for prevention of BK virus infection completed.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating antigen-specific cytotoxic T cells for treating opportunistic infections including EBV, CMV, adenoviru…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient [Phase 1]
Phase 1 trial evaluating the tolerability and safety of BD03 to prevent cytomegalovirus and BK virus reactivation in kidney transplant recip…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients [Phase 4]
A Phase 4 clinical trial evaluated the safety and efficacy of everolimus for BK virus infection in kidney transplant recipients; results wer…
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Induction Related BK Viremia in Renal Transplant Patients
This document reports the completion status of a clinical trial investigating induction-related BK viremia in renal transplant patients.